No argument there, AF is def a dick. But his response is

New Post Public Reply Private Reply Replies (3) Message Board
Tanis2476 freegriff #25911
656
No argument there, AF is def a dick. But his response is rooted in truth.

Let’s look at Orphan status vs FDA Fast tracking:

"Orphan Drug" status and "Fast Track" designations generally mean the drug will be moved to the open market faster.

"Fast tracking" is allowed by the FDA when drugs in their experimental trial phase vastly exceed expectations and/or the drug works so much better than placebo in the drug's experimental trials that those getting placebo are clearly worse off (that it would be inhumane to give them placebo when the alternative works so much better). Fast tracking is usually given after excellent results during Phase II or Phase III trials.

The FDA's drug approval process usually takes many years, and "fast tracking" shortens that time considerably.

The advantages to fast tracking are:
1. to the drug manufacturer because they have longer patent time to sell the drug without competition
2. to the patients in the general public (who are not in the experimental phase of the drug already) who may potentially need these drugs because they can get their hands on them sooner
3. to investors in such drug companies as news like this often causes their stock prices to jump


"Orphan drug" status is not as desirable. Orphan drugs are technically drugs that are required but its use will be relatively infrequent (so it's not gonna be a big money-maker). To make this easier to understand, let us say that company XYZ comes up with a drug that treats condition/disease ABC. However, condition ABC only affects, say 50,000 people. It is a legitimate disease, but it is unlikely company XYZ will profit from making the drug to treat this condition ABC. Most companies are truly in business only to make money, so company XYZ really has no reason to produce this drug because it won't make them any money. But what about the 50,000 people who have this disease? Will they be forced to suffer, even though a cure exists? So what the FDA does to remedy this problem is grant company XYZ's drug "orphan drug" status so that it has exclusive patent rights to this drug, AND probably pays the company some kind of grant money or something so that it will offset the losses that XYZ would incur by producing this non-moneymaking drug.

There is little incentive for many pharmaceutical companies to develop cures for rare diseases - those that affect fewer than 200,000 people in the US - because the small market and high cost associated with finding these types of cures discourages these companies from entering this market.

If Elto was the only thing out there to treat PLID (Adamas beat them to market) or Alzheimer’s Aggression (several companies are going through Phase III trials) The there would be a chance someone would jump. But, any pharma company knows to recoup the money for trials done on a generic drug for a rare disease is not possible unless they charge $35k+ a year. They would get skewered for this (See Epi Pen). Thus no company has been interested.

So yes, the patents, the orphan drug designation are all nice “feel good” PRs, but they ultimately mean nothing because no company as of yet sees ELTO as being worth a dime.

And you are right, big pharma has scores of people investigating this opportunities every day and ELTO is not currently on any of their radar as a product of interest. ELTO will not be the catalyst to get us to uplist. It is ESS and MANF near term, maybe MSPrecise, case closed. ELTO is not the gem, it’s a “hey, by the way, to sweeten the deal we are trying to get done for MANF or ESS, we’ll throw in Elto free of charge.

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 36

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Childhood Nutrition Advice That Lowers Mealtime Stress

Updated Category News Views 47

A toddler surviving on three bites Tuesday is not a verdict on the family table. That plain idea sits at the center of pediatric expert Kathy Shirazi’s guidance on childhood nutrition, and frankly, it deserves more oxygen than another impossible-looking lunchbox photo. In the HelloNation article released November 20, 2026, Shirazi, MD, MPH, FAAP, urges parents to judge...

Continue Reading
Prospera’s DFW Culture Win Matters Beyond the Plaque

Updated Category News Views 46

Employee survey ballots rarely make pulses race, but this one deserves more than a lazy shrug. Prospera Financial Services has landed on The Dallas Morning News’ 2026 Top Workplaces DFW list for a second consecutive year, placing in the Top Small Workplaces category. For a boutique independent broker-dealer, that is not meaningless wall décor. The people doing the...

Continue Reading
Webster First Takes Aim at the Youth Money Literacy Gap

Updated Category News Views 86

Money mistakes get expensive long before anyone calls them mistakes. That is the uncomfortable point beneath Webster First Federal Credit Union CEO John Thomasian's November 20, 2026 discussion of financial literacy: plenty of young adults are entering the real financial world with a card, a loan offer, and a phone full of banking apps, but no sturdy framework for using...

Continue Reading
VIGGO’s Mix1Pro Tests Practical Commercial Cleaning

Updated Category News Views 61

A cleaning robot earns its keep in the ugly corners, not under convention-center lights. VIGGO used the ISSA Show North America gathering in Las Vegas, held November 17–19, 2026, to introduce the Mix1Pro, a compact commercial machine aimed at indoor facilities below 53,800 square feet. That target matters. Smaller, messier sites are where autonomy can look terrific on a...

Continue Reading
Shenzhen’s 50-Year Message Carries Real Trade Weight

Updated Category News Views 68

A city once framed as a frontier fishing village is being presented as China’s sharpest recent economic before-and-after picture. At the welcome dinner for the 33rd APEC Economic Leaders’ Meeting in Shenzhen, President Xi Jinping gave guests a compact geographic guide to China’s past: Xi’an for thousands of years, Beijing for 500 years, Shanghai for 100 years, and...

Continue Reading
Swim Readiness Depends on Skills, Not Birthdays Alone

Updated Category News Views 55

A child popping up calmly after a brief dunk tells you more than a birthday ever will. That is the sensible center of Woody Alpern's guidance for families weighing whether a child belongs in the next swim level. The Atlanta swim school expert's point is refreshingly free of the usual parental race: advancement is earned through repeatable skills, comfort, and judgment in...

Continue Reading
OU's $44.3M Rural Care Plan Targets Oklahoma Care Gaps

Updated Category News Views 70

A Long Drive Is a Brutal Barrier to Care Seventy-five of Oklahoma's 77 counties sit in health professional shortage territory, a figure that ought to stop people cold. It means at least 3,500 patients per provider in those counties. That is not some abstract planning headache. It is the pregnant patient delaying a specialist visit, the family weighing an ambulance ride,...

Continue Reading
AlphaPoint's Approval Device Targets AI Attack Risk

Updated Category News Views 45

A Separate Screen May Be Worth More Than Another Patch AlphaPoint is taking a fairly old security instinct and aiming it at a very current headache: if the laptop is lying to the employee, do not let the laptop have the final say. Its newly introduced Approval Device is dedicated hardware with its own display, built to let authorized staff inspect and approve sensitive...

Continue Reading
Franklin County Trees Raise Funds and Honor Veterans

Updated Category News Views 46

Holiday charity works best when it gives people something tangible to gather around, and Franklin County has found a pretty sturdy version of that formula. Its eighth annual Festival of Trees opens at 4 p.m. Saturday, November 21, at the Franklin County 11/30 Visitors Center in downtown Chambersburg, carrying the theme A Salute To Veterans. More than 80 decorated trees...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Recent Class Action Against Fluor Corporation Investors

Updated Category News Views 230

Class Action Lawsuit Against Fluor Corporation Recently, a prominent plaintiffs' law firm has taken action against Fluor Corporation (NYSE: FLR) in order to advocate for investors who acquired shares within a specific period. Key Information for Investors Investors who purchased FLR securities during the designated time frame could become lead plaintiff representatives,...

Continue Reading
Harnessing Apple Stock Dividends for a Steady Income Stream

Updated Category News Views 313

Understanding Apple Stock's Dividend Potential Apple Inc. (NASDAQ: AAPL) has made significant strides in the tech industry, and with a strong performance in the stock market, many investors are looking at ways to monetize their investments through dividends. As shares of Apple continue to perform impressively, the company is on track to reach a staggering $4 trillion...

Continue Reading
Transforming Finance: Infosys BPM Introduces AI Automation

Updated Category News Views 244

Revolutionizing Finance with AI-Powered Solutions Infosys BPM is making waves in the finance and accounting services sector with its innovative AI agents designed to enhance operational efficiency. This new solution addresses the pivotal component of accounts payable, where businesses can now witness significant efficiency gains, improved accuracy, and a superior user...

Continue Reading
Bitmine Immersion Technologies Boosts Crypto Holdings to $10.7B

Updated Category News Views 288

Bitmine Immersion Technologies Expands Crypto Holdings Significantly Bitmine Immersion Technologies, Inc. has made headlines by announcing its impressive digital asset portfolio, which now includes 4.285 million Ethereum (ETH) tokens, totaling a staggering $10.7 billion in crypto and total cash holdings. This remarkable achievement illustrates the company's steadfast...

Continue Reading
CIB Marine Bancshares Shares Positive Earnings Growth Insights

Updated Category News Views 190

CIB Marine Bancshares, Inc. Delivers Strong Third Quarter Results BROOKFIELD, Wis. — CIB Marine Bancshares, Inc. (the Company or CIB Marine) (OTCQX: CIBH), the holding entity for CIBM Bank, reported an impressive performance for the third quarter of 2025, revealing an uptick in both net interest income and operational improvements in the banking and mortgage divisions....

Continue Reading